The concept of bad news, coupled with the philosophy of nursing care, integrates professional experience as a solid foundation for a greater capacity for communication between health professionals, clients and families. In oncology the multidimensional complexity inherent in the transplantation of hematopoietic precursors is a reality. When complications arise, the future expectations of the client/family are unequivocally disrupted. Notwithstanding this in the literature on the subject, stands a focused concern on the quality of nursing interventions that respond effectively to customer needs/ family when face to your expectations, it is shaken before the appearance of translated complications in poor news. Objective develop technical, scientific and communication skills on the transmission of bad news, the provision of specialized care in oncology nursing in the context of Hematopoietic Precursors Transplantation. Narrative bibliographic research in databases; opinion survey of nurses through Application of a Questionnaire with three open questions, to know their perception on the subject; dynamization and programming of sessions directed to a multidisciplinary group for training of communicational skills guided by expert where the steps of the SPIKES protocol were explored. 100% of the nurses surveyed unanimously confirm the existence of bad news in this professional context, and the graft failure is the one that stands out. As for its difficulties, what emerged was the management of the emotional reactions of the client and family, pointing out as a greater need for theoretical/ practical training. There were training sessions of communication skills with a clinical psychologist, using the role play technique. The sessions covered a significant number of members of the nursing and medical team, with high adherence and participation. The evaluation of the degree of satisfaction was at a very good level. The positive impact of the training sessions on communicational skills alone was an indicator of effective response to the training needs identified in the opinion poll.
The effectiveness of the role play technique is referred to as excellent for Bonamigo and Destefani (2010), considered superior to theoretical presentations. Aware that the adequate number of sessions is difficult to attain due to the complexity and multidimensionality of the subject, we still consider that the strategy used was an important contribution to the training of the nurses who experienced it. In order to ensure ongoing training, this experience allows us to state that should be continued and included under the clinical supervision in training, innovative project for the development of technical and communication skills in the transmission of bad news in the context of Hematopoietic Precursors Transplantation. The scientific evidence substantiates the results obtained by demonstrating the effectiveness of this training resource in this particular area. However, we understand that this training model can be transmitted to other sensitive areas of nursing practice, where the domain of communication techniques is central to raising the quality of nursing care, the image of organizations and translating health gains. Disclosure of conflict of interest: None.
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Investigating patients and caregivers utility and needs for an educational programme dedicated to stem cell therapy for autoimmune diseases H Faivre-Lescat, H Jessop, C Tourette-Turgis, S Pons, C Baudry, L Terriou, M Riviere, V Poindron, C Sordet, C Aknouche, R Tipton, I Yakoub-Agha and D Farge-Bancel
Over 2000 autologous hematopoietic stem cell transplants (HSCT) have been performed in Europe for a range of autoimmune diseases (AD). There is a lack of specific information for patients in this AD group. This study investigated the utility and needs for a dedicated patient education programme to address patients and caregivers additional concerns with stem cell therapy for AD. Embedding qualitative research in trials is an established approach for understanding the intervention process and the scope for integrating interventions into routine practice. Three successive approaches were used to identify the patients quest for knowledge about their AD and treatments as well all their medical, psychological and social consequences: (a) a workshop with AD caregivers to identify the items of interest, (b) to elaborate the questionnaire subsequently delivered to patients and care givers from the national network and (c) semi-structured interviews conducted with voluntary patients already treated by stem cell therapies and their caregivers. Data were analyzed using both a framework and descriptive approach. 12/12 caregivers (doctors, nurses, physiotherapists, dieticians and social workers) and 20/ 29 AD patients participants perceived the development of an educational programme as necessary. Three topical subjects are essential for more than 50% of patients and their caregivers, 'disease awareness', 'treatment awareness' and 'awareness of preventative measures to avoid complications after HSCT'. Two others issues appeared essential for more than 50% of patients: 'better understanding of the various stages during the HSCT procedure', and 'when to notify the S517 B E MT doctor or transplant center'. Several types of patient education have been developed from this study: (1) the SFGM-TC (French Society of Bone Marrow Transplantation and Cellular Therapy) booklet originally developed for haematological diseases has been adapted for AD patients, (2) the SFGM-TC internet site now offers access to specific AD information for patients and caregivers at www.ma-thec.com. This offers the ability to provide information despite the distance from the transplant center but also to the possibility to facilitate closed supervised support groups. Patient involvement in provision of these educational materials is vital to ensure that the provided information is adapted to their individual AD, needs and circumstances. The additional need to provide specific information for AD patients about HSCT is being addressed through this project and could be disseminated through the EBMT nurses group. Disclosure of conflict of interest: None.
Since research shows that evidence based practice leads to improved patient safety and quality, we started a journal club for nurses at The Centre for Haematology, Karolinska University Hospital with support from the Nurse Unit Managers as well as the Director for the Centre. The aim of the study was to evaluate the participant's experiences after 1 year of journal club. Three nurses with post-graduate and doctoral qualifications identified the need for a forum for the centre's nursing staff to meet and discuss nursing literature and current evidence for practice. These nurses became the core group that created and ran the journal club. All nursing staff at the centre's six units (inpatients and outpatients) were invited to participate in the journal club. Prior to the journal club meeting the participants identified a clinical question and two journal club hosts identified 2-3 scientific articles that addressed the chosen clinical question. Participants read the articles prior to the meeting with the help of Oncology Nursing Society's (ONS) Clinical Article Review Form, which was translated to Swedish. During the 2 h long meeting the articles were discussed using the Clinical Article Review Form. Discussions included whether the articles provided answers to the clinical question and whether recommendations could be made for clinical practice. The discussions were later summarised in a PowerPoint presentation so that the participants could present the findings of the journal club meeting back to colleagues within their own unit. Between September 2015 and May 2016 five journal club meetings were held. Examples of clinical questions discussed included; 'Does Scrub the Hub reduce the risk for central venous catheter infections?', 'Does physical activity reduce cancer patients' fatigue?" and "Does Chemo Brain exist?' In June 2016 an online survey with open-ended and closed-ended questions was sent to all 13 nurses who participated during the first year in order to evaluate their experiences of journal club. The respondents (70% = 9 out of 13) had all worked for 45 years as a registered nurse and 50% had post-graduate qualifications. 100% of the respondents thought that it was appropriate to read 2-3 articles for each journal club, that the clinical questions raised were relevant and that it was appropriate to have a 2-h timeframe for each meeting. 83% thought that every 6 weeks was appropriate. 67% used the clinical review form when reading the articles and 83% gave feedback to their colleagues. Several of the participants gave comments in the survey, such as 'Fun and interesting to discuss clinical nursing questions in a more evidence based manner. Surprising to discover how little evidence there is for everything we do' and 'We discuss the results a lot in my (work) group. I have become more aware and brought up questions with patients. I feel I have more knowledge of these topics and am better equipped to give patients advice'. The results of the evaluation showed that the respondents experience with this model of a journal club was positive and that the reviewed articles and discussions about current evidence were fed back to colleagues at the centre. As a result we have continued with this model of journal club at our centre. Disclosure of conflict of interest: None. Content: this booklet contains three sections: practical advice for drug administration (antifungal agents and immunosuppressive treatment); a fact sheet about transplant (graft transfusion); and post-transplant complications support (GVHD, VOD/SOS). The role of nurses for medication administration, drug monitoring and patient education is emphasized. There are also practical tools such as mucositis assessment and GVHD scoring. Conclusion: this booklet will be released in paperback. It will be distributed to all French nurses working in adult and pediatric transplant centers. All comments are welcome through the GFIC-GM website to improve this guide to best meet nurses' needs. Disclosure of conflict of interest: None. A significant and enduring late effect of cancer survivors is psychological distress driven by fear that the cancer will recur (FCR). This includes persistent anxiety, hypervigilance and catastrophic thoughts about the disease returning or progressing. This has a significant impact on quality of life. Research into FCR has been limited and there is no agreed treatment model. The author, and colleagues, developed a group intervention using acceptance and commitment therapy (ACT). ACT promotes psychological flexibility, and living with vitality alongside one's difficulties while effectively managing pain and distress. It is useful for coping with chronic problems and uncertainty. Aims: to help participants be less preoccupied with their worry and anxiety; to increase engagement with the things that mattered to them; and to improve quality of life. The group was advertised using fliers in clinics and MDTs, and mailed to patients who had completed cancer treatment ⩽ 1 year. Eligible participants were adults at ⩾ 3 months following completion of treatment, in remission and without a psychiatric or neurological disorder. Intervention: six structured 90 min sessions, at weekly intervals, using experiential and didactic methods to convey the 6 core processes of ACT to participants: open up to painful feelings; relate differently to thoughts; be present; observe own experience; identify what matters (values); do what matters. Outcomes were assessed using a range of validated psychological measures, implemented pre-and post-intervention. Results: 9 participants (4F, 5M) aged 33-64, attended. 6 attended all sessions; 3 attended 5/6. 7 underwent allogeneic SCT; 1 autologous SCT; 1 chemotherapy. Initially, some participants found the techniques uncomfortable (mindfulness), unusual (observer self) or counterintuitive (accept painful thoughts and feelings, rather than avoid them) but, ultimately, all gave positive verbal feedback about using them. 83% of participants completing all 6 sessions showed improvements on every assessment tool, including overall quality of life (Table 1) . Group, mean scores for each domain of AQOL-8D questionnaire (graph 1) reflect improvements in every category other than pain. One participant's scores worsened, but he reported subjective benefits from attending. The intervention received strongly positive endorsement from its participants, who reported that it helped them to cope with their FCR better and to begin living with more vitality. They cited ACT processes specifically as being helpful, as well as meeting others who had similar anxieties (group effect). Disclosure of conflict of interest: None. Introduction: cytomegalovirus (CMV) infection is the most prevalent viral infection in patients undergoing allogeneic stem cell transplantation (ASCT). In clinical practice, Valganciclovir is the first-line for the outpatient treatment of CMV infection. In case of non-oral tolerance the alternative is intravenous (IV) Ganciclovir (GV), whereas when peripheral blood counts are poor and renal function is optimal the option is IV Foscarnet (FT). In most centres, to receive these intravenous treatments, patients must be readmitted. Objectives: to analyze the feasibility and the impact in the hospital resources of the domiciliary treatment of the CMV infection in a home care unit (HCU) specialized in patients with haematological malignancies. Patients and methods: at our centre, when ASCT patients with CMV infection require IV treatment, they have the possibility of being treated at home by our HCU if they have clinical stability and home o1 h from our centre. In patients with a peripheral venous catheter, GV was given at a dose of 5 mg/kg twice daily, with two daily visits at home for 60 min each of them, whereas the administration of FT (60 mg/kg/12 h IV) required also two daily visits at home for~90-120 minutes since previous IV hydration with calcium, potassium and magnesium was necessary. Patients with a central venous catheter, GV was given in a single at home visit of 15 min using an intermittent infusion pump (IIP) CADD-Legacy, while the use of this device made it possible to reduce the duration of home visits to 60 min in patients treated with FT. In order to facilitate de central line insertion in our patients, since February 2012 we have a team of nurses trained in the placement of peripherally inserted central catheter (PICC). Results: between November 2000 and February 2012, 108 episodes of CMV infection were treated at home in 69 patients undergoing ASCT. Median (range) age was 46 (19-71) years. GV was administered in 53 (49%) episodes and 23 (43%) of them were administered using IIP. In the rest of the episodes (n = 55; 51%) FT was administered requiring two daily visits at home in all cases. Readmission was necessary in 33 (30%) of the episodes, but none related to complications of the treatment. The median duration of home treatment was 12 (1-42) days with a total number of visits by HCU of 1485. Since we have the possibility of placing PICC, this device is a recommendation for at home Allogeneic hematopoietic stem cell transplant is a curative treatment for malignant hematological disease. The main complication is graft-versus-host disease (GVHD) which occurs in 40-60% of patients with skin, gut and liver frequently involved (1) . When gut is affected by GVHD, especially in grades 3-4 or steroid resistant GVHD, it results in nausea, vomiting, severe abdominal pain and profuse diarrheas (41500 ml/24 h) which appear to be humiliating, distressing and adversely affecting patients' quality of life (QoL), risk of fall, skin integrity and morbidity (2-3). The use of a Fecal Management System (FMS) for fecal incontinence in GVHD could improve patients' QoL and the management of complications related to digestive disorders (4). The aim of this project was to assess the use of FMS on comfort and general condition of patients with severe and/or steroidresistant gastrointestinal (GI)-GVHD and to evaluate the impact of this device on care quality and organization. Patients with stage 3 or 4 GI-, steroid-resistant GVHD were prospectively included from a single French Hematology Stem cell transplant unit between 2010 and 2015. During this period, fecal management device was used as a routinely care device and proposed to all patients. Median age of the 19 included patients was 53 years (28; 65); 68% (n = 13) were men. Median stool volume was 4.2 liter (1.5; 8.0). All patients had an altered sleep quality due to wake up, stand up or mobilize themselves with a median frequency of 13 times per night for stools emission or changes. All patients have experimented at least one accidental fall during these nocturnal wakes up. Before the use of FMS, all patients were suffering of cutaneous lesion localized on the anal region and performance status, according to WHO scale, was evaluated at II, III and IV for 16% (n = 3), 37% (n = 7) and 47% (n = 9) of the patients, respectively. Median length of stay in the unit was 93 days (73; 140) and mortality rate was 84% (n = 16). Among the 19 patients included in this study, 53% (n = 10) were in the FMS group and 47% (n = 9) were in the standard care group. Median use duration of the FMS was 24 days (4.8; 39) and the device was regularly changed, as recommended, with a 1.5 (1; 2.8) median number of device per patient. Reasons of withdrawing the FMS were fecal leaks in 3 patient and accidental removal for another one. After the used of FMS all patients start to recover from skin lesion. Sleep quality was improved and no night accidental fall was observed in the FMS group. Nursing care was also improved with an easiest and safer way to evacuate and quantify patient's stool, which allowed a better monitoring (exact stool volume) of the severity and the response of the GVHD to treatment. Fecal Management System, in the context of stage 3 and 4 steroid-resistant GI-GVHD, appears to be an easy usable device which seems to improve patient's Quality of Life by reducing skin lesion due to frequent diarrheas, avoids accidental falls down due to frequent stand up by night and finally leads to a better sleep quality for patients who are already weak and tired. This preliminary study highlights also the role of FMS on the quality of care by reducing the risk of exposure to stools for nurses and by improving the supportive care relationship between the patient and allied and healthcare professionals. Disclosure of conflict of interest: None. -5] . Our survey aimed to: describe current modalities of related-donor (RD) care; explore HSCT-NC's perceptions of RD care. The HSCT-NCs registered with the EBMT Nurses Group and working in HSCT-adult units were sent a questionnaire by mail, focusing on: (1) professional profile; (2) HSCT unit organization regarding donors' information, work-up, harvesting and follow up and (3) perceptions about related-donors' care. The questionnaire was available in 6 languages (Dutch, English, French, Italian, Portuguese and Spanish). Results: 101 HSCT-NCs from 20 countries responded to the survey and 67% confirmed that, as HSCT-physicians (HSCT-P), they care for both donors and recipients. Hematologists (55%), HSCT-NCs (22%) and HSCT-P (16%) evaluate recipients of HSC donation. Potential donors are contacted by HSCT-NCs (48%), hematologists (10%), HSCT-P (8%) and are informed about donation and transplantation before HLA tests by HSCT-P (38%), HSCTNCs (25%) and hematologists (16%). Haematologists (25%), HSCT-NCs (39%) and HSCT-P (18%) communicate HLA test results to patients (17%), to all potential donors (25%) or to compatible donors (16%). An information interview dedicated to the compatible donor is performed either by the HSCT-P (31%) or by the HSCT-NC (28%), and sometimes by the haematologist (16%). This interview takes place when HLA results are available (35%) or at the time of pre-donation check-up (55%). Follow-up is performed by medical consultation (39%), telephone interviews (22%) or questionnaires (12%). Even if 76% of HSCT-NCs consider that the RD's needs are addressed, in their opinion the choice to donate (29%), information (33%), financial assistance (45%), psychosocial support (45%) and follow-up (36%) should be improved. Demanding situations in RD's care have been experienced by 81% of HSCT-NCs 1-3 times (89%), 4-6 times (8%) and 7-9 times (3%) in the last year. These situations are mostly linked to reluctant donors (35%), to doubts about the 'free choice' of the donor (26%) and the informed consent (12%) or to conflicting family relationships (6%). In the last year, 30% of HSCT-NCs have felt to be in conflict of interest 1-3 times (89%), 4-6 times (6%), 7-9 times (1%). Finally, 47% of respondents thought that the only way to protect RDs' free choice to give or not is to organise RDs' care by a fully independent unit. Our survey shows that RD's care organisation is not standardized and that many aspects are to be improved, notably regarding ethical aspects. Conflict of interest and RDs' 'true choice' are main issues to be considered. Disclosure of conflict of interest: None. Our hematology ward shows a chronic shortage of admission beds available to patients, who need to be readmitted with complications after chemotherapy or stem cell transplantation (SCT). We believe this is due to more intensive treatments and a longer period of hospitalization. In 2015 we readmitted 149 patients on external wards, compared to 105 in 2014. In daily practice this leads to a number of difficulties for both patients and their healthcare professionals, such as the continuity of care and a lack of knowledge on hematology specific problems. Thus to provide the appropriate care to patients readmitted on other wards, according to JACIE guidelines and above all to secure patient safety we established a consultation team; including a hematologist, resident, nurse practitioner and specialized nurses from the hematology ward. The team supports through focusing on recognition and reducing hematology specific complications in an early stage through consultation and co-treatment. Professional development in the field of hematological care takes place via clinical lessons, discussing case reports or attending a multidisciplinary consultation. Psychosocial counseling of patients through bedside consultation. Results and conclusion: from May 2016 until November 2016 we performed 135 consultations. Our first priority was securing both our patients and colleagues sense of safety, as well as reducing the number of complications and days of admission. We aim to implement a more structural solution by means of a consultation team that would be available to all hematology patients admitted on other wards. However, we believe that more beds, as well as specialized nurses and staff available on the hematology ward itself would be preferable. For this moment we have to take our responsibility and give the extra care within the existing possibilities of our ward. Discussion: how far should the responsibility of the consultation team reach? Support vs taking over? After performing 135 consultations in 6 months in addition to our regular work, could we state that the consultation team has a right to exist and should be formalized? Disclosure of conflict of interest: None. The EBMT NG, in collaboration with Nurses No Frontiers (NNF) and Childhood Cancer International (CCI), organised the Training course for HSCT nurses in Guangzhou, China on 26-27th February 2016. More than 150 nurses attended from more than 10 regional hospitals. Discussion and practical issues were explored thanks to the efficient assistance of intrepreters who were medical assistants of the same multidisciplinary hospital teams from Second Affiliated Hospital, Sun YatSen University and Nanfang Hospital. Some issues of our training were, basics of quality management, standards and nurses' education, transplant process, infections, CVC management, transfusion support, mucositis/oral care, nausea/vomiting, GvHD and palliative care. Objectives: development of Nursing Education Programmes in Outreach Countries, training of professionals able to guarantee a correct quality approach to transplant patients in emerging countries due to rapid technological and scientific advances. Establish contacts between nurses from China and the organization of the Education programme: first visit as a basic course module, to train the trainers; second visit with an advance course module; and third visit to maintain competency. Develop further projects: visit exchange with European hospitals and E-learning modules based on JACIE standards. A simple questionnarie was given to enquire if their needs had been reached, and what would be necessary to improve. There were 49 responses in Chinese; translation was needed. Similar answers have been collated. Question 1: how do you assess different issues: Mucositis: most perform general care with mouth rinses; four had assessment and prevention tools, and three did not use scoring. Pain: five had some assessment and scoring tools, ten had no pain assessment implemented or sufficiently developed, and found difficulties managing pain. Two expressed a lack of psychological care. CVC: most had CVC, PICC training and assessment, well developed. GvHD: some nurses used assessment tools, monitoring and prevention of GvHD, while others said that there was not good management. Question 2: would you find a standardized tool useful in your daily practice? Most answered yes, it would set up procedures to follow standards and help make decisions to implement care or improvement. Question 3: from the following list choose 3 topics you would like to learn more about? Order of priority of the topics chosen: GvHD; CVC management; nurse assessment tools SOPs; mucositis and nutrition. Others: patient safety, HPSC processing and VOD. Question 4: do you find these kind of meetings useful? If so, why? All yes. It increases knowledge regarding care management of HSCT patients; it is a chance to exchange thoughts, difficulties, experiences and learn differences between countries; it is an opportunity to learn skills on patient safety. Question 5: one thing to take home and share with colleagues. There was a great variety of answers about the issues of the course, one was highlighted: palliative care. They express that palliative care is not that developed and it would be worth promoting in China. Training was a great learning experience for everyone. All nurses enjoyed the course and would repeat it, wishing to learn more in depth in order to be able to properly assess their patients. We are all looking forward to continuing our collaboration with second step advanced training in Guangzhou next year, and new beginnings with NNF and CCI. Disclosure of conflict of interest: None.
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Hematopoietic stem cell transplant nurse coordinator's (HSCT-NC's) perceptions of related donor care: a European survey A Polomeni, C Bompoint, M Badoglio, J Stringer, C Eeltink, S Liptrott, A Babic, G Batipaglia and M Mohty Hematopoietic stem cell related-donation raises specific clinical and ethical issues. Current practice of overlapping recipient and donor care may raise a conflict of interest within teams, underplay medical and psychosocial risks to the donor and compromise the volunteer status by a lack of confidentiality [1
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Nursing in the shadow of battle: the story of B., a Syrian refugee in Israel I Porat, Y Diamand, G Jacope, R Ofir, I Zaidman and M Ben-Arush Rambam Hospital, Haifa, Israel For over 7 months, B., a 6-year-old girl from war-torn Syria, had waited for this moment. Standing in her white dress, a party crown on her head, she said her goodbyes to the oncology department staff after undergoing a successful bone marrow transplant. When B. began to suffer from unexplained bleeding and hemorrhages all over her body, her parents realized that the only chance for their daughter to survive was to obtain treatment in Israel, and so they brought her to the border fence. Since April 2011, civil war has raged in Syria, forcing some 8 million people to leave the country after their homes and villages were destroyed. Most of them have found shelter in Lebanon, Jordan, Turkey and European countries. Our tiny country is also providing Syrian citizens with a unique type of humanitarian assistance. Israel has been providing medical treatment to Syrian fighters, civilians and children since 2013. To date, some 144 wounded have reached Rambam Hospital, suffering from shock, burns and bullet injuries. The patients have included 31 children, who arrived mostly without family and were treated in the pediatric ward.
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The IDF found B. at the border fence and brought her to the hospital in Nahariya where she was diagnosed with severe aplastic anemia. S.A.A. is defined as pancytopenia due to failure of the bone marrow to produce normal blood cells. In children, the treatment of choice is an urgent bone marrow transplant from a family member. Following the medical evaluation, B. was transferred to the transplant unit of the Ruth Rappaport Children's Hospital, in order to undergo a BMT from her brother, who was selected as the appropriate donor. She remained in the hospital on her own until the IDF were able to locate her family and smuggle her mother into Israel along with vials of blood for tissue analysis and donor identification. In Israel, we act through the belief that every individual deserves medical treatment as a human being, without connection to personal background and without discrimination based on religion, race or gender. The treatment that B. received was at the highest professional level, without regard for expense. B.'s treatment was a challenge both for the caregivers as well as for the girl and her mother. Barriers of trust and language, religious differences and prejudices are only some of the difficulties that the staff encountered during the process. Despite the dissonance and political chasms that separate Israeli and Syrian culture, we succeeded in creating a strong and special relationship. This helped us achieve success in B.'s treatment and she was able to return to her family, healthy and happy. At the farewell party we held for the girl celebrating her return home, the mother described her initial fear at treatment in an enemy country, and its transformation into joy at the support and love they enjoyed from the staff. Our study will describe this special treatment experience from the viewpoint of the caregivers as well as that of B. and her mother. Disclosure of conflict of interest: None. The European Blood and Marrow Transplantation (EBMT) and Nurses No Frontiers (NNF) Nurses Groups (NG) mission is promoting excellence in patient care through international collaboration, education, research and science. The EBMT Nurses Group plays an essential role in Haematology and Haematological Stem Cell Transplantation nursing. The group was created 32 years ago and now has over 900 contact members in more than 60 countries worldwide. The NNF association has as its purpose the support of the international network of experienced nurses in favour of nurses in developing countries, lifelong formation, on-site training, education, nursing education, patients' information, standardization procedures, the organization of conferences and events. Therefore, EBMT and NNF NG Mission is to enhance and value the nurses role all over the world, supporting and sharing knowledge through communication, advocacy, research, training and education. The two groups are dedicated to improving the care of adult and paediatric patients receiving SCT and works towards promoting excellence in care through recognizing, building upon and providing evidence based practice. With this in mind we have established the cooperation between our two groups and together with local support we aim to provide nurses updates and educational events in LMIC. We have many support requests but until now we were able to provide support in Guangzhou, China and on December 9th and 10th we will be in Tata Memorial Centre in Mumbai, India. This 2 days intensive course is supported by local organizers and we are looking forward to provide an exciting training course and to network with local nurses and allied health care professionals. We sincerely hope that local nurses will benefit of educational event provided and that this will be only the first of numerous collaborative activities between our nurses. Disclosure of conflict of interest: None. Introduction: HSCT is an effective treatment for many hematologic disorders, and globally over 70 000 procedures/ year are performed in more than 70 countries. However, not all the countries have enough resources and expertise to establish an HSCT program; patients are often forced to emigrate for transplant, with heavy social and economic consequences. In 2015, the non-government organization IUC identified the HCH as a site for a possible transplant program: HCH was working as a hub centre for 2000 patients/year, affected by onco-haematological malignancies. Furthermore, due to the Syrian and Iraqi migrations, thalassemia patients (especially children) were increasing (almost 130 new cases more/month). A HSCT expert team from Italy (IM), following a visit to the HCH, reported a positive conclusion on the feasibility of an HSCT program. The HCH already had available most of the required technologies, including a positivepressure, HEPA-filtered unit. Kurdish health team has been evaluated: nurses did not have a BMT experience and they were mainly working in Adults Oncology settings. Bedside nursing came up with many challenges, due to cultural issues and nurses' education. Methods and results: a capacity building project was submitted to the IADC, and funded in March 2016. The Italian counterpart provided over 30 highly experienced volunteer specialists (physicians, nurses, technicians and one physicist), each with a specific mission plan. The joint Italian and Kurdish team started-up the center, with a first autologous transplant, in adults, done in June 2016 and 6 more shortly after. In October 2016, the 1st allogeneic transplant was performed in pediatric thalassemia patient. 3 more patients followed and are ongoing. The start-up process has included nurse selection and training. 20 nurses have been selected, through different steps: the group is now made of young nurses, with short working experience; English speakers. Nursing involvement considered the following: (1) dedicated training process: lectures and training on field by Italian experienced BMT nurses; (2) development of clinical expertise together with BMT protocols, operating guides and clinical documentation; (3) definition of a nursing responsibility tree; (4) plan of implementation of nursing work organization (for example, key nursing role and responsibilities; shifts). A survey has been conducted, among Kurdish nurses, about satisfaction levels: they reported mainly good level of satisfaction about being involved in the project; a number of nursing/challenges emerged: learning needs, nursing workload, pediatric patient management, cultural issues in bedside nursing. Training program and collaboration among nursing teams are still on. Strategies to improve long distance nursing collaboration (Italy-Kurdistan) are under analysis. Conclusion: the HCH is the only one center performing auto/allo HSCT in all the Iraqi Nation. The international cooperation has been fruitful and may contribute to improve the capabilities of centers even in critical geographic areas and is therefore a valuable instrument to implement nation-to-nation scientific exchanges. The clinical results obtained so far are excellent. However, further nursing training and long distance collaboration is needed to assure the Kurdish nursing team to work independently, according to safety and stability criteria. Strategies to overcome cultural issues with influences in nursing practice have to be implemented. Disclosure of conflict of interest: None.
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Previously published NO017 Change of protective isolation in paediatric SCT; from the past to the present and one step back D Sijtsma, G Dronkert, H Mekelenkamp, M van Harmelen, R Bredius and A Lankester Leiden University Medical Center, Leiden, The Netherlands Paediatric SCT in Europe was first implemented at the Leiden University Medical Centre in 1968. The protective isolation protocol was extensive. Patients were treated in laminar air flow (LAF) units with air filtration (HEPA) until day 100 according to a strict sterile protocol. Parents of the patients were obliged to stick to the same protocol as health care professionals (HCP's) and could hardly participate in the daily care. In 1995 the LAF units changed to Ultra Clean Rooms (UCR) including air filtration (HEPA) and the regime got less strict. Within the rooms, both HCP and parents had to wear gloves, a mask and a disposable apron, but not sterile anymore. Parents were allowed to stay with their child all day but not during the night. These changes improved the quality of the stay and care for patients, parents as well as HCP considerably. The total duration of protective isolation became shorter than in the LAF unit due to new medical insights and changes in supportive care. In 2015 the SCT unit moved to a newly build location within our hospital. Whereas HCP'S had to comply to the same protective isolation guidelines, these were less strict for parents and limited to good hand hygiene on condition that parents had no infectious illness. Moreover, rooming in was also allowed during the night, which improved the quality of the isolation time of the child. After moving to the new unit and implementing the new isolation guidelines, an increase in respiratory viral infections was observed in the SCT patients. Therefore, a retrospective analysis of the occurrence of respiratory viral infections was performed to evaluate the protective isolation guidelines. Two groups of 18 children each, transplanted during the same seasonal period (October-March) in two consecutive years in the former (group A) and new unit (group B) and applying the respective isolation guidelines were compared. Second, we planned to evaluate the parental experiences with the current isolation rules. The frequency of diagnosed respiratory viral infections during the admission for SCT was 6 six out of 18 patients (33%) in group A, and eight out of the 18 patients (44%) in group B. In group A, all infections presented before or after the period of protective isolation. In contrast, in group B five out of the eight patients with a respiratory viral infection were first diagnosed during the period of protective isolation. Results about the parental experiences are pending. Our analysis suggests that the higher frequency of viral respiratory infections during the admission period as observed in group B is linked to less strict protective isolation and rooming-in guidelines for parents. This prompted us to revise these guidelines. We ask parents to wear mouth masks in order to further limit the risk of transmitting respiratory viral infections. When parents have a rhinitis or respiratory tract infection we recommend to limit rooming-in. They also have to wear gloves plus an apron and they are not allowed to sleep with the child. Special emphasis is again put on hand hygiene. We as nurses try to keep the balance between optimal parental care and maximal safety for the patient to avoid infections. As a consequence we have the task to inform and support parents to comply with the hygiene protocol and facilitate optimal contact between patients and parents. Together, this will contribute to an optimal outcome for our patients and their parents. Disclosure of conflict of interest: None. We know from previous research that sibling stem cell donors are in a vulnerable situation (2, 3, 4, 5, 6) . Negative experiences as well as positive experiences, in addition to a closer relationship with the sick sibling have been described. Sibling donors are often concerned about the outcome of the transplantation for their sick sister or brother and feel responsible for doing what is necessary to help a family member (a.a.). The life situation of sibling stem cell donors is most certainly affected by the donation, making it possible that a transition will occur. We know hardly anything about the transitional process that occurs among healthy siblings who donate stem cells to a brother or sister. The focus of this study is how the approach of sibling stem cell donors changes from before the donation to one year after it. The aim of this study was to prospectively investigate the main concerns associated with sibling stem cell donation and how healthy siblings deal with these concerns before and after donation. Ten healthy sibling donors, 5 men and 5 women, with a median age of 54 years (range 26-66 years) were included in this study when they were due to donate stem cells to a brother or sister. Data were collected prospectively on three occasions (before the donation and three and twelve months after it) through 29 in-depth interviews, which were recorded and transcribed verbatim for analysis by the Grounded Theory method developed by Charmaz (2010). The grounded theory of this study describes the efforts of the ten donors to fulfil their duty as a sibling by doing what they considered necessary in order to help. Their efforts were summarised in a process wherein the grounded theory generated three main categories; prepare, promote and preserve, demonstrating various ways of fulfilling one's duty. A clear path of transition through fulfilment is evident, starting before the donation and until one year after donation. In addition, the main categories contain several sub-categories revealing the strategies used to fulfil one's duty (Figure 1 ). Being a sibling stem cell donor means doing what you have to do to fulfil your duty and if possible, saving the life of a seriously ill brother or sister. The relationship between the siblings is developed and strengthened by the donation process. Sibling stem cell donation seems to be about fulfilment and a thorough understanding of the social process of fulfilment when donating stem cells to a sibling enables directed and person centred support in every phase of the donation process. It also enables a targeted discussion during the evaluation in order to identify those siblings lacking the core incentive for donation. The self-management support might be more targeted towards the strategies used by the donors to promote and preserve the sibling relationship in particular. This grounded theory constitutes a framework for long-term follow up, that is, the first post donation year, which is requested by donors but not always delivered by the transplant professionals. Although there have been major advances in the treatment of childhood cancer, cancer continues to be the leading cause of death in children due to disease. Parents are at risk for psychological disturbance when a child is dying and the threat of the loss of a child can lead to a process of anticipation of grief that may or may not be adaptive. The intensity of parental grief has been attributed to the disruption in natural order that occurs when parents outlive their children, feelings of failure, and breakdown in family structure and so on. Our objective was to investigate the extent of some risk factors for complicated grief among parents whose child died from cancer. Sample: 22 caregivers of 22 terminally ill children with cancer (9 girls and 13 boys; average: 8 and 7 years old). Diagnoses were: leukemia (30%), trunk tumor (25%), Ewing's sarcoma (20%), neuroblastoma (15%), osteosarcoma (5%) and glioblastoma (5%). Material: Questionnaire for Risk Assessment of Complications in Resolution of Grief, in Primary Caregivers of Children with Cancer. Eleven participants in the sample present feelings and/or emotions of high intensity. Most caregivers do not report uncontrolled symptoms throughout the process, however 10 have experienced moderately stressful uncontrolled symptoms during the last few days. Also included in this dimension is the Delay in the diagnosis of the disease in which most of the participants answered that it was scarce. According to the observed results we consider it is essential to study the uncontrolled symptoms in the last days, children and parents need a symptom management plan of care. Emotional support and satisfaction of psychic, social and spiritual needs must also be emphasized. 
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Shaare Zedek Medical Center
A unit for autologous bone marrow transplant for hematological patients has been established in Shaare Zedek medical center 3 years ago. The patients meet with the doctors for the treatment plan usually following the diagnosis. From the point of view of a part of the patients, the process appears simple, short term and promises cure. In reality, the process is long term, including aggressive chemotherapy prior to the transplant. The treatment is highly aggressive and toxic with many physical and mental side effects for the patient and his/her family. The transplant process requires hospital admission for about a month in an isolation room. No one is allowed in the room except for close relatives and the medical staff. The social worker, part of the caregiving staff, accompanies patients and families from the initial diagnosis through this taxing and stressful process. Most patients are young, average 45 years, in the middle of their careers, from a broad spectrum of occupations, education as well as social status, representing Israeli society. Goals To accompany and empower patients by means of giving them tools to cope with the transplantation process which is a crisis situation in the midst of their lives; to teach patients self-awareness; promote quality of life for the patients especially during the stay in the isolation room by way of creating a safe domain. The following tools have been utilized: The Empowerment Method: an advanced view of the powers and experiences of patients that constitute resources in addressing crisis; work of hope: finding unique meaning in a life crisis. This work is based on therapeutic conversations that took place inside the isolation room with~30 patients, mostly men; average age was 50, during the past 3 years. With the understanding that a patient goes from the public sphere to a private one-the isolation room-my entrance into the room was based on the ability and willingness of the patients to go into a treatment dialogue at that point and time. From the narratives of the patients, a few themes were extracted that were repeatedly discussed by most patients: Fear of death, post-traumatic issues, fear of isolation, relationships, mind and body, children, faith and closure. As S. A., a 49-year-old man, said: 'I'm afraid to give up and die. Help me to stay alive. But if I die, I want to know that I have left no unfinished business.' From the therapy sessions it appears that the central issues that bother the patients belong to the private space and the coping with it. The process of treatment helps patients to go from the private sphere back to the public one. It seems essential for the patients in the isolation room, undergoing autologous bone marrow transplant, to have therapy sessions with a qualified social worker as part of the holistic care. 'Having a room of his own' in the process enables an opportunity to examine the inner self esteem and strengths of the patients thereby patients learn to contribute to themselves from themselves. Disclosure of conflict of interest: Between the needs of the patient, and the hospital's ability to supply them.
Sleep disorders are a common problem in oncohaematological patients with a prevalence ranging from 35% to over 50%. The prevalence of sleep disorders in patients undergoing HSCT was recorded in 32% in patients at preadmission, 77% during hospitalization and 28% after discharge. Sleep disorders can lead to an increased number of negative outcomes, such as chronic pain, respiratory distress, obesity, stress and anxiety. Objectives: the study has two main objectives: (1) assessing the quality of sleep of adult patients undergoing HSCT at time of pre-transplant (T0), at day +30 after transplantation (T1), at day +100 (T2), at day +180 (T3) for autologous and allogeneic transplant and at day+360 (T4) after allogeneic HSCT; (2) identify possible determinants of sleep disorders in relation to some variables such as age, diagnosis, type of transplant conditioning regimen and the development of complications such as infectious events and GvHD. A longitudinal-prospective multicenter exploratory research design was used with a convenience sampling strategy for the period from 1 March 2015. The inclusion criteria are: patients aged 418 years, undergoing HSCT in Italian BMT centers and make the follow-up at the same transplant program where they have had the HSCT for at least 6 months for autologous transplantations and for at least 1 year for allogeneic transplantations. Sleep quality was measured by administering the Italian version of the Pittsburgh Sleep Quality Index (PSQI) at different moments (T0-T4). The sleep diary was filled out by the patient every morning during hospitalisation. Other data such as fatigue and pain were collected through the visual analog scale CLAS and numeric rate scale (NRS) respectively. The total of enrolled patients were 221; here we report the partial data of 40 patients with a mean age of 53.6 years, including 22 males and
18 females were analyzed. Forty-five per cent of patients had a diagnosis of leukemia, 30% of plasma cell disorders, 22.5% lymphoma and 2.5% other. Half of the patients were subjected to allogeneic transplantation and the other half to autologous transplantation. The results of the analysis of the sleep diary showed that: during the second week of hospitalization, there was an increase in sleep onset latency (30-38′ to get to sleep), the number of awakenings was from 3.1 to 4.1 per night, the wake-time after sleep onset was 1 h and 54 min for allogeneic, and 1 h and 30 min for autologous patients and the time spent in bed was 8 h and 22 min for allogeneic, and 8 hours and 15 minutes for autologous HSCT recipients. The sleep efficiency was 68% for patients undergoing allogeneic HSCT and 80% for autologous HSCT. Sixty-five per cent of patients undergoing allogeneic transplantation and 50% of patients undergoing autologous transplantation did not take sleepinducing therapy, while 30% of patients undergoing allogeneic transplantation and 40% of autologous patients started taking therapy for sleep disorders during hospitalization. These partial data show that during aplasia, there was an increase of sleeping problems for both types of transplantation, which is also reported in the literature. It emerges that the patients' sleep quality during hospitalization of patients who underwent autologous transplantation is better compared to that of allogeneic HSCT recipients. Disclosure of conflict of interest: None. The Hematology Department at the University Hospital of Umeå is responsible for the allogeneic stem cell transplants for adults in The Northern Medical Region of Sweden. The region makes up nearly half of Sweden geographically and the distance from north to south is more than 1000 km. Approximately 140 allogeneic patients are followed up on a regular basis and as the patients come from the entire region it is a challenge to conduct these follow ups.
Frequent contact with the patient after an allogeneic stem cell transplantation is important both for monitoring GvHD and the management of immunosuppressive treatment. A follow-up visit for a newly transplanted patient can take up to 3 days; 1 day to travel to Umeå, 1 day for the visit at the hospital and the journey back and 1 day for recovery at home. The frequent travelling is a burden for the patient, and creates a need to reduce the number of hospital visits. Method: a telemedical project funded by the Regional Cancer Centre was launched in 2014. Webcameras were purchased and routines set up for the visits in collaboration with our hospitals IT department to ensure a sustainable and technically secure solution. Visits are generally done from the patient's home, using their own computer. A hyperlink sent to the patient is used to reach a virtual meeting room where the visit is conducted. After a year the patients and physicians evaluated the telemedical visits using a survey of questions pertaining to: Overall impression; technical quality; the experience of personal contact in a telemedical visit; whether the patients experienced addressing their problems via the hyperlink as equally safe as doing it in a physical meeting; the experience of having decreased the number of hospital visits.
Results: from the start a great interest was shown in the telemedical visits from both patients and physicians. Visits were initially conducted with only allogeneic patients but have over time been offered to other patients as well. A recent development is that emergency visits can also be conducted via hyperlink. A patient who calls and presents a problem can immediately be connected for a telemedical visit. Visits that could previously take several days for the patient now take only 30 min. The reduction in travel expenses has also meant an economic gain for the entire region. Immunosuppressed patients generally travel unaccompanied in a taxi. The need for expensive taxi rides from the different parts of the northern region to the hospital in Umeå has thus been reduced. The evaluation of the telemedical visits has shown that both the patients and the physicians experience the same level of personal contact and security at telemedical visits as at regular hospital visits. They also appreciate the reduction in travels. Conclusion: telemedical visits have successfully been introduced at our hematological department. Aside from the purchase of webcameras, the telemedical visits are done within the framework of existing economic means. The reduction in travels will hopefully lead to reduced strain and increased quality of life for the newly transplanted patients. Since the introduction of this method the number of patients who are followed by telemedical visits has increased dramatically. Evaluations of telemedical visits will be made continuously and the aim is for every coworker to be able to send a link for a telemedical visit from their work e-mail. Disclosure of conflict of interest: None.
